$TZYM Ocera Therapeutics, Inc. Insider Trading Week 50/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ocera Therapeutics, Inc. in week 50/2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 13 2017 | TZYM | Ocera Therapeutics ... | DOMAIN ASSOCIATES | 10% Owner | Sell | D | 0.00 | 47,963 | 0 | 0 | 48 K to 0 (-100.00 %) |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | DP VI Associates, L.P. | 10% Owner | Sell | D | 0.00 | 15,731 | 0 | 0 | 15.7 K to 0 (-100.00 %) |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | Domain Partners VI, L.P. | 10% Owner | Option Exercise | D | 0.67 | 20,150 | 13,501 | 0 | |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | Domain Partners VI, L.P. | 10% Owner | Option Exercise | D | 0.67 | 20,150 | 13,501 | 0 | |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | Domain Partners VI, L.P. | 10% Owner | Sell | D | 0.00 | 1,857,036 | 0 | 0 | 1.9 M to 0 (-100.00 %) |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | DP VIII Associates, L.P. | 10% Owner | Sell | D | 0.00 | 7,333 | 0 | 0 | 7.3 K to 0 (-100.00 %) |
Dec 13 2017 | TZYM | Ocera Therapeutics ... | Domain Partners VIII, L.P. | 10% Owner | Sell | D | 0.00 | 988,285 | 0 | 0 | 988.3 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 0.67 | 11,969 | 8,019 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 0.67 | 30,827 | 20,654 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 0.67 | 30,826 | 20,653 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 7.84 | 37,500 | 294,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 7.38 | 491,550 | 3,627,639 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 3.76 | 160,000 | 601,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 2.98 | 348,600 | 1,038,828 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Option Exercise | D | 2.15 | 289,200 | 621,780 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Sell | D | 1.52 | 70,000 | 106,400 | 0 | 70 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Grais Linda S | President and CEO | Sell | D | 1.52 | 230,000 | 349,600 | 0 | 230 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Option Exercise | D | 7.85 | 20,000 | 157,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Kjellson Nina S | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Option Exercise | D | 2.15 | 208,350 | 447,953 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Option Exercise | D | 3.06 | 300,000 | 918,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Sell | D | 1.52 | 200,000 | 304,000 | 0 | 200 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Bukofzer Stan | Chief Medical Offic ... | Sell | D | 1.52 | 2,500 | 3,800 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Option Exercise | D | 5.51 | 20,000 | 110,200 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | James Steven P | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 7.50 | 70,000 | 525,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 2.15 | 102,300 | 219,945 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 3.76 | 75,000 | 282,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 7.50 | 55,000 | 412,500 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Option Exercise | D | 2.98 | 123,300 | 367,434 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Sell | D | 1.52 | 150,000 | 228,000 | 0 | 150 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Byrnes Michael | CFO and Treasurer | Sell | D | 1.52 | 13,000 | 19,760 | 0 | 13 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Dere Willard H | Director | Option Exercise | D | 2.43 | 20,000 | 48,500 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | Dere Willard H | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 50.88 | 2,652 | 134,934 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 48.00 | 2,083 | 99,984 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 7.85 | 20,000 | 157,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 7.85 | 20,000 | 157,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 1.84 | 2,992 | 5,505 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Option Exercise | D | 1.84 | 2,992 | 5,505 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Sell | D | 1.52 | 11,969 | 18,193 | 0 | 12 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WEBER ECKARD | Director | Sell | D | 1.52 | 344,719 | 523,973 | 0 | 344.7 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 13.25 | 20,000 | 265,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Sell | D | 1.52 | 5,000 | 7,600 | 0 | 5 K to 0 (-100.00 %) |